Your search returned 11 results.

Results
	1.	Evaluation and Treatment of Febrile Ulceronecrotic Mucha-Habermann Disease With Ruxolitinib and Tocilizumab as Guided by Cytokine Profile. MedStar authors: DiLorenzo, Ashley PMID: 34643656 Year: 2021 Citation: JAMA Dermatology. 157(11):1381-1383, 2021 11 01. Institution: MedStar Washington Hospital Center Department: Medical Dermatology Residency Medline publication type: Journal Article Form of publication: Journal Article All authors: Brooks J, DiLorenzo A, Habeshian K, Keller MD, Kirkorian AY, Lotke M, Wu R DOI: https://dx.doi.org/10.1001/jamadermatol.2021.4047 Add to cart (remove)
	2.	Pazopanib for the treatment of breast cancer. [Review] MedStar authors: Swain, Sandra M PMID: 22233389 Year: 2012 Citation: Expert Opinion on Investigational Drugs. 21(2):217-25, 2012 Feb. Institution: Washington Cancer Institute Medline publication type: Journal Article Research Support, N.I.H., Extramural Review Form of publication: Journal Article All authors: Amiri-Kordestani L, Swain SM, Tan AR DOI: http://dx.doi.org/10.1517/13543784.2012.652304 Add to cart (remove)
	3.	Pharmacokinetics and pharmacodynamics of a single dose Nilotinib in individuals with Parkinson's disease. MedStar authors: Yusuf, Nadia PMID: 30906562 Year: 2019 Citation: Pharmacology Research & Perspectives. 7(2):e00470, 2019 04. Institution: MedStar Washington Hospital Center Department: Neurology Medline publication type: Journal Article Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Ahn J, Arellano J, Fowler AJ, Hebron ML, Howard HH, Lawler A, Liu X, Matar S, Moussa C, Mundel EE, Pagan FL, Peyton M, Schwartz SL, Starr NJ, Torres-Yaghi Y, Wilmarth B, Yusuf N DOI: https://dx.doi.org/10.1002/prp2.470 Add to cart (remove)
	4.	Recurrent erythematous plaques on sun-exposed sites in an African American boy with chronic granulomatous disease. MedStar authors: Turegano, Mamina M PMID: 24528905 Year: 2014 Citation: Journal of the American Academy of Dermatology. 70(3):576-80, 2014 Mar. Institution: MedStar Washington Hospital Center Department: Medicine/Dermatology Medline publication type: Case Reports Journal Article Research Support, N.I.H., Intramural Form of publication: Journal Article All authors: Brownell I, Cowen EW, De Ravin SS, Lee CC, Malech HL, Turegano MM DOI: http://dx.doi.org/10.1016/j.jaad.2013.09.051 Add to cart (remove)
	5.	Weekly paclitaxel and concurrent pazopanib following doxorubicin and cyclophosphamide as neoadjuvant therapy for HER-negative locally advanced breast cancer: NSABP Foundation FB-6, a phase II study. [] MedStar authors: Swain, Sandra M PMID: 25542269 Year: 2015 Citation: Breast Cancer Research & Treatment. 149(1):163-9, 2015 Jan. Institution: Washington Cancer Institute Medline publication type: Clinical Trial, Phase II Journal Article Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Bhatt K, Bury MJ, Fehrenbacher L, Flynn PJ, Geyer CE Jr, Goel R, Jacobs SA, Johannes H, Julian TB, Mamounas EP, Provencher L, Rastogi P, Robidoux A, Stella PJ, Swain SM, Tan AR, Thirlwell MP, Wolmark N DOI: http://dx.doi.org/10.1007/s10549-014-3221-2 Add to cart (remove)
	6.	Results of a prospective phase 2 study of pazopanib in patients with advanced intermediate-grade or high-grade liposarcoma. MedStar authors: Priebat, Dennis A PMID: 28832986 Year: 2017 Citation: Cancer. 123(23):4640-4647, 2017 Dec 01 Institution: Washington Cancer Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Chawla SP, Kaiser PE, Milhem MM, Portnoy DC, Priebat DA, Samuels BL, Skubitz KM, Somaiah N, Staddon AP, Stepanski EJ, Walker MS DOI: https://dx.doi.org/10.1002/cncr.30926 Add to cart (remove)
	7.	Novel somatic KIT exon 8 mutation with dramatic response to imatinib in a patient with mucosal melanoma: a case report. MedStar authors: Atkins, Michael Benjamin PMID: 25003536 Year: 2014 Citation: Melanoma Research. 24(5):509-11, 2014 Oct. Institution: Washington Cancer Institute Form of publication: Journal Article All authors: Al-Refaie W, Atkins MB, Parks K, Rapisuwon S DOI: http://dx.doi.org/10.1097/CMR.0000000000000102 Add to cart (remove)
	8.	Phase I trial of dasatinib and ixabepilone in patients with solid tumors. MedStar authors: Herbolsheimer, Pia M Jelinek, James S Kapoor, R Perry, David J Smith, Karen L Swain, Sandra M Verma, Nitin Veytsman, Irina PMID: 22392508 Citation: Investigational New Drugs. 31(1):92-8, 2013 Feb. Institution: MedStar Washington Hospital Center Washington Cancer Institute Department: Radiology Medline publication type: Clinical Trial, Phase I Journal Article Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Herbolsheimer P, Jelinek J, Kapoor R, Perry D, Smith KL, Swain SM, Verma N, Veytsman I DOI: http://dx.doi.org/10.1007/s10637-012-9805-y Add to cart (remove)
	9.	Optimal sequencing of ibrutinib, idelalisib, and venetoclax in chronic lymphocytic leukemia: results from a multicenter study of 683 patients. MedStar authors: Cruz, Allan-Louie PMID: 28453705 Year: 2017 Citation: Annals of Oncology. 28(5):1050-1056, 2017 May 01 Institution: MedStar Washington Hospital Center Department: Hematology/Oncology Medline publication type: Journal Article Form of publication: Journal Article All authors: Barr PM, Brander DM, Cheson BD, Claxton DF, Cruz AL, Daniel C, Fanning M, Foon K, Gashonia L, Goy A, Henick Bachow S, Hill BT, Howlett C, Isaac K, Kennard KH, Kiselev P, Lamanna N, Lenhart J, Mato AR, Nabhan C, Pu JJ, Schuster SJ, Skarbnik AP, Svoboda J, Timlin C, Ujjani CS, Winter AM, Yacur M, Zent CS DOI: https://dx.doi.org/10.1093/annonc/mdx031 Add to cart (remove)
	10.	Cholesterol ester transfer protein inhibition by TA-8995 in patients with mild dyslipidaemia (TULIP): a randomised, double-blind, placebo-controlled phase 2 trial. MedStar authors: Brewer, H Bryan PMID: 26047975 Year: 2015 Citation: Lancet. 386(9992):452-60, 2015 Aug 1. Institution: MedStar Health Research Institute Medline publication type: Clinical Trial, Phase II Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Barter PJ, Brewer HB, Ford J, Hovingh GK, Kastelein JJ, Rader DJ, Round P, Saleheen D, van Deventer SJ DOI: http://dx.doi.org/10.1016/S0140-6736(15)60158-1 Add to cart (remove)
	11.	A phase 1 study of lenalidomide and ibrutinib in combination with rituximab in relapsed and refractory CLL. MedStar authors: Trivedi, Neel PMID: 29610115 Year: 2018 Citation: Blood Advances. 2(7):762-768, 2018 Apr 10 Institution: MedStar Washington Hospital Center Department: Hematology and Oncology Medline publication type: Journal Article Form of publication: Journal Article All authors: Cheson BD, Khan N, Ramzi P, Skarbnik A, Trivedi N, Ujjani C, Wang H DOI: https://dx.doi.org/10.1182/bloodadvances.2017015263 Add to cart (remove)

Powered by Koha